Dulaglutide modulates the development of tissue-infiltrating Th1/Th17 cells and the pathogenicity of encephalitogenic Th1 cells in the central nervous system
PeptideStack does not provide medical advice, diagnosis, treatment recommendations, dosing guidance, or instructions for human use
Diarrhoea tends to be mild to moderate in severity, whilst constipation may be more problematic in patients with pre-existing bowel disorders
Structure Patients treated with tesamorelin for 52 weeks (T-T group) showed no change between Weeks 26 and 52 in mean trunk fat (increase of 0.1 kg in Study 1 and decrease of 0.5 kg in Study 2, respectively, compared with an increase of 1.4 kg in patients in the T-P group in Study 1 and an increase of 1.09 kg in Study 2, respectively) nor was there a change from Week 26 baseline in mean lean body mass (decrease of 0.1 kg in Study 1 and increase of 0.1 kg in Study 2, respectively, compared with a decrease of 1.8 kg in patients in the T-P group in Study 1 and a decrease of 1.7 kg in Study 2, respectively)
Considering that RYGB leads to increased meal-induced activation of NE-expressing NTS neurons in mice [36], it would be interesting to determine the impact of their silencing or ablation on food intake and body weight, with preliminary data suggesting a modest and temporary effect [83]
Both are made by Lilly